Matches in Wikidata for { <http://www.wikidata.org/entity/Q74789046> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q74789046 description "article scientifique publié en 1998" @default.
- Q74789046 description "artículu científicu espublizáu en xunetu de 1998" @default.
- Q74789046 description "im Juli 1998 veröffentlichter wissenschaftlicher Artikel" @default.
- Q74789046 description "scientific article published on 01 July 1998" @default.
- Q74789046 description "wetenschappelijk artikel" @default.
- Q74789046 description "наукова стаття, опублікована в липні 1998" @default.
- Q74789046 name "Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group" @default.
- Q74789046 name "Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group" @default.
- Q74789046 type Item @default.
- Q74789046 label "Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group" @default.
- Q74789046 label "Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group" @default.
- Q74789046 prefLabel "Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group" @default.
- Q74789046 prefLabel "Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group" @default.
- Q74789046 P1433 Q74789046-28AD7EFD-1069-4D5A-BEB4-B2E01197AD20 @default.
- Q74789046 P1476 Q74789046-44653375-13F1-4C32-8538-C5E9749C2F99 @default.
- Q74789046 P2093 Q74789046-04FB0C93-F4D4-484B-AEEE-AC5482F8751E @default.
- Q74789046 P2093 Q74789046-08C84678-42A1-4999-BDC3-2BA275A32378 @default.
- Q74789046 P2093 Q74789046-08FB40BF-B1CD-4E8E-953A-BF20AC0AB611 @default.
- Q74789046 P2093 Q74789046-44DD700F-BB0B-44A8-AAE7-D045B1C986EC @default.
- Q74789046 P2093 Q74789046-4A6549A5-00B2-4042-B0A3-47B23CF3EFB6 @default.
- Q74789046 P2093 Q74789046-674EE695-A634-47ED-9F19-3768DB78C2C4 @default.
- Q74789046 P2093 Q74789046-80D494AF-AA69-4EC1-BA19-7BC923A2D85E @default.
- Q74789046 P2093 Q74789046-AD7F0512-EBDA-4DB3-8D9A-A36C1DC4533F @default.
- Q74789046 P2093 Q74789046-BD212978-CE54-4E5E-ABC2-DF068907036F @default.
- Q74789046 P2093 Q74789046-D301E17C-133F-4302-8FCC-532FB901E7D3 @default.
- Q74789046 P304 Q74789046-CCA9F81B-DB95-4203-8C8A-35B43CB34178 @default.
- Q74789046 P31 Q74789046-D9D68D3F-62B5-46CF-921D-2BA0405CB2C1 @default.
- Q74789046 P356 Q74789046-1E7AF73D-E120-4E06-B917-CCF5B1054130 @default.
- Q74789046 P433 Q74789046-CA662754-8732-468E-8160-5160992142E0 @default.
- Q74789046 P478 Q74789046-024C22E5-EDFB-441F-9FBB-8DD1B0DC9E85 @default.
- Q74789046 P577 Q74789046-BB4192FA-CFCF-4B95-B070-69E1DA851524 @default.
- Q74789046 P698 Q74789046-8305E098-1545-4255-8653-F1E23B241BB2 @default.
- Q74789046 P921 Q74789046-04D08F8D-5508-4439-A4BB-CC91F771F9CF @default.
- Q74789046 P921 Q74789046-7389CC8A-6436-4851-889E-A155C20A10AE @default.
- Q74789046 P921 Q74789046-EA24141A-5F86-4ADB-BDD9-1353C7357C24 @default.
- Q74789046 P356 (SICI)1097-0142(19980715)83:2%3C291::AID-CNCR13%3E3.0.CO;2-O @default.
- Q74789046 P698 9669812 @default.
- Q74789046 P1433 Q326041 @default.
- Q74789046 P1476 "Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group" @default.
- Q74789046 P2093 "Behre G" @default.
- Q74789046 P2093 "Büchner T" @default.
- Q74789046 P2093 "Eimermacher H" @default.
- Q74789046 P2093 "Grote-Metke A" @default.
- Q74789046 P2093 "Hiddemann W" @default.
- Q74789046 P2093 "Kerkhoff A" @default.
- Q74789046 P2093 "Kern W" @default.
- Q74789046 P2093 "Kubica U" @default.
- Q74789046 P2093 "Rudolf T" @default.
- Q74789046 P2093 "Wörmann B" @default.
- Q74789046 P304 "291-301" @default.
- Q74789046 P31 Q13442814 @default.
- Q74789046 P356 "10.1002/(SICI)1097-0142(19980715)83:2<291::AID-CNCR13>3.0.CO;2-O" @default.
- Q74789046 P433 "2" @default.
- Q74789046 P478 "83" @default.
- Q74789046 P577 "1998-07-01T00:00:00Z" @default.
- Q74789046 P698 "9669812" @default.
- Q74789046 P921 Q264118 @default.
- Q74789046 P921 Q411478 @default.
- Q74789046 P921 Q412223 @default.